Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Accumulated Expenses readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 72.17% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 72.17% decrease, with the full-year FY2025 number at $1.8 million, down 72.17% from a year prior.
  • Accumulated Expenses hit $1.8 million in Q4 2025 for Treace Medical Concepts, down from $7.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $13.7 million in Q2 2024 to a low of $1.2 million in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $4.7 million (2022), compared with a mean of $4.9 million.
  • The widest YoY moves for Accumulated Expenses: up 357.4% in 2025, down 88.23% in 2025.
  • Treace Medical Concepts' Accumulated Expenses stood at $1.5 million in 2021, then soared by 308.41% to $6.2 million in 2022, then grew by 21.44% to $7.5 million in 2023, then decreased by 12.9% to $6.6 million in 2024, then tumbled by 72.17% to $1.8 million in 2025.
  • The last three reported values for Accumulated Expenses were $1.8 million (Q4 2025), $7.2 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.